Anirban Kundu (Ph.D.) (@Lab_AKundu) profile picture

Faculty @uarizona. Passionate about asking fundamental questions related to cell signaling, metabolism, and epigenetics using #RCC as a model system.

Tucson, Arizona, USA
Joined March 2020
Photo by Anirban Kundu (Ph.D.) (@Lab_AKundu)Photo by Anirban Kundu (Ph.D.) (@Lab_AKundu)Photo by Anirban Kundu (Ph.D.) (@Lab_AKundu)Photo by Anirban Kundu (Ph.D.) (@Lab_AKundu)Photo by Anirban Kundu (Ph.D.) (@Lab_AKundu)Photo by Anirban Kundu (Ph.D.) (@Lab_AKundu)
Anirban Kundu (Ph.D.) retweeted
Absolutely in awe and admiration for @rachnatshroff, FASCO who is supporting the permanent endowment of a @ConquerCancerFd , @ASCO Foundation Young Investigator Award, while she fights cancer herself. All my love and support to you. Please donate: support.conquer.org/p2p/site…
3
17
1
59
5,249
Anirban Kundu (Ph.D.) retweeted
Congratulations to Chandel lab for demonstrating that a metabolite once considered purely “toxic” may actually be a key signaling molecule in cells and organisms. This study demonstrates that l-2-HG functions in signaling by regulating epigenetic state via KDM4/H3K9me3 demethylase and linking redox state to transcriptional repression. The study provides initial words in “Metabolic Language” of transcription. nature.com/articles/s41586-0… @NU_BMG_SQE @NUFeinbergMed @Nature @CellPressNews @ScienceMagazine @MolecularCell @theNASciences @theNAMedicine @NorthwesternU @NatMetabolism
2
16
80
6,822
Anirban Kundu (Ph.D.) retweeted
New preprint w/ the Dupage lab! FSP1 KO in Tregs / Tcells promotes tumor suppression, highlighting the therapeutic value & single-agent potential of FSP1 inhibition. A new paradigm for targeting ferroptosis in the immune system (not just in cancer cells). biorxiv.org/content/10.1101/…
14
1
59
5,335
Anirban Kundu (Ph.D.) retweeted
Today we honor dads who nurture families, lead by example, and show love in countless ways. Your impact is felt every day and we’re grateful for all you do. Happy Father’s Day to all who carry that role with heart! 🧡 #FathersDay
4
6
415
Anirban Kundu (Ph.D.) retweeted
Please RT and help us get the word out. Scott Dixon @sjd956 and I are co-organizing the first @FASEBorg #Ferroptosis conference this summer! Awesome line up of speakers and room for additional short talks! Save the date & come join us July 27 - 31, 2025! 🤩events.faseb.org/event/11797…
1
83
4
127
19,237
Anirban Kundu (Ph.D.) retweeted
Eating less can lead to a longer life: massive study in mice shows processes beyond metabolic regulation drive how the body responds to caloric restriction. What mattered most were traits related to immune health and red-blood-cell function. nature.com/articles/d41586-0…
1
5
917
Felt good advocating for Kidney Cancer Patients. Thanks, Carlos Martinez, legislative Correspondent to @RepRaulGrijalva, for carefully listening to our agenda. @UAUrology @UAZCancer @kidneycan @KidneyCancer
1
2
5
239
So proud of you
Sunil Sudarshan, M.D., professor in the @UABHeersink Department of Urology, has been named the next Associate Director for Basic Science at @ONealCancerUAB, effective October 1, 2024. 📰 buff.ly/4dsXr2a
3
111
Anirban Kundu (Ph.D.) retweeted
Zhijian “James” Chen, winner of the 2024 #LaskerAward, explains how he used an unbiased approach to identify cGAS and its mechanism of DNA sensing in this QnA by @PNASNews: pnas.org/doi/10.1073/pnas.24… #Lasker2024 #UTSWMed @UTSWMedCenter #LaskerLaureate
27
1
126
14,487
#UTSW biochemist Zhijian "James" Chen, Ph.D., wins the Albert Lasker Basic Medical Research Award, sometimes called “America’s Nobel,” for his discovery of the cGAS enzyme, which senses invading pathogens and triggers immune response. bit.ly/3MQjHIr @LaskerFDN
8
77
12
410
38,024
Thanks @TennessenLab for including us in this important study. It's made a critical contribution to the growing knowledge of the oncometabolite, L-2HG. #RCC #Kidneycancer.
Our latest paper on hypoxia, oncometabolites, and mitochondrial metabolism is now out! sciencedirect.com/science/ar…
1
1
119
Anirban Kundu (Ph.D.) retweeted
Contrary to how tumors operate while still in the kidney, metastatic kidney cancers rely heavily on mitochondrial metabolism, according to new research from HHMI Investigator Ralph DeBerardinis (@RJDLab) & colleagues @CRI_UTSW. hhmi.news/3X7db5U
10
16
5,238
Anirban Kundu (Ph.D.) retweeted
Ever wonder how #resistance to #rapalogs develops in #RCC and why despite introduction ~20 yrs ago, mTOR mutations not found? @kcputsw provides some answers pnas.org/doi/10.1073/pnas.23…
6
12
3
51
6,677
Anirban Kundu (Ph.D.) retweeted
Everything you've ever wanted to know about #Ferroptosis in Health and Disease! Massive review from many in the field. Happy to have contributed and huge thank you for the leadership from Carsten Berndt / Marcus Conrad @Conrad_Lab. 🙂 doi.org/10.1016/j.redox.2024…
36
4
124
17,466
Anirban Kundu (Ph.D.) retweeted
It's official! Excited to be co-organizing the @FASEBorg conference on “Ferroptosis, Oxidative Stress, and Lipid Metabolism: From Mechanisms to Therapy” w/ Scott Dixon @SJD956 !! Next summer July 27-31 2025! Save the date. More details coming soon. 😀 #Ferroptosis #LipidTime
4
50
5
186
22,087
jci.org/articles/view/171294 Happy to share our latest publication in @jclinicalinvest addressing a mechanism of metabolic liability in #kidneycancer. Sincere thanks to the reviewers, and the editor for their input in improving our work
1
4
1
7
1,063
I personally thank @SUNILSUDARSHAN4 lab, @UABUrology, and scholars from @UABHeersink and @ONealCancerUAB for their help in our project.
1
88
Thanks for funding @theNCI, @CDMRP, and @AmerUrological. I also appreciate the support from @BenLeeUrology, @UAZCancer, and @UAUrology when I was addressing the comments from the reviewers of the manuscript.
74